Regional Analysis

Monkeypox (Mpox) Diagnosis Market Regional Insights

To learn more about this report, Request sample copy

Dominating Region: North America

North America dominates the monkeypox (Mpox) diagnosis market with share of 37.2% in 2024, which can be attributed to strong local healthcare infrastructure and government support for disease control and prevention. Additionally, the region is home to many leading medical technology companies that are actively engaging in the development and commercialization of diagnostic solutions for emerging health threats.

Fastest-Growing Region: Asia Pacific

Asia Pacific region exhibits the fastest growth in this market. Rapid economic development and rising healthcare spending have strengthened regional capabilities to address public health priorities. At the same time, population growth and dense urbanization in many Asian countries increase the risks of infectious disease outbreaks, driving the need for robust diagnostic preparedness.

Monkeypox (Mpox) Diagnosis Market Outlook for Key Countries

Diagnostic Leadership in the U.S.

The U.S. leads in monkeypox diagnostic innovation, bolstered by an advanced healthcare infrastructure and swift test development initiatives. In September 2023, Hologic, Inc. received Emergency Use Authorization (EUA) for its monkeypox test, significantly enhancing diagnostic response capacities across the country. The U.S. Centers for Disease Control and Prevention (CDC) has actively supported the implementation of rapid testing systems, ensuring robust diagnostic solutions are available nationwide, thereby setting a benchmark for global disease surveillance and response.

Strong Public Health Framework in Canada

Canada’s proactive public health approach includes enhanced surveillance and diagnostics for managing monkeypox outbreaks. In July 2023, the Public Health Agency of Canada (PHAC) expanded testing capabilities to address the rise in cases, underscoring the nation’s commitment to effective outbreak management. Through collaboration with provincial health agencies, Canada has strengthened its monitoring systems and implemented public health campaigns, aiming to detect and contain cases swiftly to protect vulnerable communities and prevent further spread.

Strengthening Disease Surveillance in Japan

Japan has adopted a cautious yet robust approach to monitoring zoonotic diseases, including monkeypox, focusing on preparedness and early response. In August 2023, Japan’s Ministry of Health announced enhanced disease surveillance and response strategies to detect zoonotic infections promptly. These initiatives include improved laboratory capacity, integrated diagnostic systems, and public health education programs. Japan’s proactive stance underscores its commitment to preventing potential outbreaks, safeguarding public health, and fostering a resilient healthcare framework for emerging infectious diseases.

Expanding Diagnostic Infrastructure in China

China's commitment to expanding diagnostic infrastructure is a major driver of market growth, fueled by government initiatives and high healthcare demand. Large-scale investments in modernizing healthcare facilities and integrating advanced diagnostic technologies are enhancing the accessibility and quality of medical services across urban and rural areas. Additionally, China's focus on AI-driven diagnostics and digital health solutions is accelerating early disease detection and treatment efficiency.

Focus on Awareness and Test Development in India

India's emphasis on raising awareness about healthcare and investing in test development is a significant driver of market growth. Government campaigns and healthcare initiatives, such as Ayushman Bharat, are improving public understanding of disease prevention and the importance of early diagnosis. Simultaneously, India is focusing on the development of affordable, accurate diagnostic tests, supported by both local innovation and collaborations with global entities. This combination of awareness-building and test advancements is driving greater adoption of diagnostic solutions, fueling market expansion across the country.